drugset / Trial / NCT00618579

Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin

NCT00618579

Phase 1 Completed 15 enrolled ThromboGenics BioInvent International AB · collab
RandomizedParallel-groupDouble-blind

Summary

Administration of LMWH in healthy male subjects treated with TB-402 and administration of TB-402 in healthy male subjects treated with warfarin

Timeline

Start
2008-02
Primary completion
2008-06
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject TB-402 Monoclonal antibody
Subject Warfarin Small molecule

Indications

No indication recorded.